T2 Biosystems' stock extends losing streak despite FDA appro

Shares of T2 Biosystems extended their losing streak to two days Wednesday.

Related Keywords

, Biosystems Inc , Article Normal , Anthrax , Typhus , Plague , Fda , Medical Equipment Supplies , Healthcare Life Sciences , Medical Diagnostic Equipment Supplies , Medical Devices Apparatus , Diagnostic Therapeutic Devices , Regulation Government Policy , Financial Performance , Share Price Movement Disruptions , Ownership Changes , Acquisitions Mergers Shareholdings , New Products Services , Corporate Actions , Product Service Approvals , Corporate Industrial News , Divestments , Products Services , Political General News , Health , Medical Conditions , Vector Borne Zoonotic Diseases , Infectious Diseases , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , T2 Biosystems Inc , Tattoo , Regulation , Government Policy , Share Price Movement , Disruptions , Acquisitions , Mergers , Shareholdings , New Products , Services , Product , Service Approvals , Corporate , Industrial News , Products , Political , General News , Vector Borne , Zoonotic Diseases , Medical Equipment , Supplies , Healthcare , Life Sciences , Medical Diagnostic Equipment , Medical Devices , Apparatus , Diagnostic , Therapeutic Devices ,